| Amplicons | Failed | Monomorphic | Polymorphic | Polymorphic amplicons* | In silico SNP validation |
---|
Random ESTs | 223 | 58 | 72 | 93 | 56.3% | |
in silico pSNPs | 269 | 41 | 69 | 159 | 69.7% | 51.8% |
in silico pSCHs | 97 | 14 | 57 | 26 | 31.3% | 21.3% |
TOTAL | 589 | 113 | 198 | 278 | 58.4% | |
- ESTs were selected at random or chosen because they contained pSNPs or pSCHs in the MELOGEN database. Columns show the number of amplicons that failed to amplify or gave bad quality sequences, and monomorphic and polymorphic amplicons between SC and PS. The percentages of polymorphic amplicons and in silico SNPs that were validated are shown in the last two columns. (*) Polymorphic amplicons rate was calculated without considering failed amplicons.